Beximco Pharmaceuticals Limited (BST:R2WA)
0.4840
+0.0060 (1.26%)
At close: Oct 16, 2025
Beximco Pharmaceuticals Market Cap
Beximco Pharmaceuticals has a market cap or net worth of €347.65 million as of October 17, 2025. Its market cap has increased by 37.42% in one year.
Market Cap
347.65M
Enterprise Value
399.00M
Revenue
373.79M
Ranking
n/a
PE Ratio
6.78
Stock Price
€0.48
Market Cap Chart
Since January 3, 2000, Beximco Pharmaceuticals's market cap has increased from 36.78M to 347.65M, an increase of 845.32%. That is a compound annual growth rate of 9.10%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 16, 2025 | 347.65M | 18.91% |
Dec 30, 2024 | 292.37M | -45.57% |
Dec 28, 2023 | 537.15M | -9.71% |
Dec 29, 2022 | 594.94M | -33.15% |
Dec 30, 2021 | 889.99M | 9.12% |
Dec 30, 2020 | 815.57M | 175.99% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 272.75B |
Siemens Aktiengesellschaft | 186.50B |
Deutsche Telekom AG | 140.15B |
Allianz SE | 139.24B |
Siemens Energy AG | 90.23B |
Rheinmetall AG | 80.06B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 72.65B |
Deutsche Bank Aktiengesellschaft | 57.45B |